Clinical response to statins: mechanism(s) of variable activity and adverse effects. - Wikidata - wikimedia - TriplyDB

Clinical response to statins: mechanism(s) of variable activity and adverse effects.

Clinical response to statins: mechanism(s) of variable activity and adverse effects.

http://www.wikidata.org/entity/Q37881964

about

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins.Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial.Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.Molecular mechanisms of statin intolerance Intolerance to statins: mechanisms and management.Pharmacogenomics of lipid-lowering therapies.Lipid-lowing pharmacogenomics in Chinese patients.Seventeen years of statin pharmacogenetics: a systematic review.Hepatitis C Virus-Genotype 3: Update on Current and Emergent Therapeutic Interventions.Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity.Association of genetic variations with pharmacokinetics and lipid-lowering response to atorvastatin in healthy Korean subjects LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia.

P2860

Q34680467-79EBC5F1-C5F9-424A-AC2A-3D678CBB5280 Q34834399-68CB5DDF-9231-466B-A585-3C6D2C8CF3C5 Q35284449-0DDFEC9A-901B-4357-B775-44ABD94B6900 Q35970280-A5070D7C-E37C-4F13-983A-2136656C4ECD Q36958324-AF403A0F-BF57-483C-BC29-FE675B8E5CCC Q37577161-3B8CE58F-8574-47AD-972F-33744C43A9E9 Q38112823-BC22049C-1F3C-4966-BAE5-C9550CFEDEA5 Q38129422-41693914-88BC-4197-902D-4AE9386B05C3 Q38670109-B7EAEE88-532E-4D89-9827-47B72E8B9B8C Q38728564-2754BC71-ABC9-41C8-8244-BF94C25EF39D Q41526681-FE6ED41C-0B3E-4DE0-A2E2-90CA44C2FE2A Q42291683-BF34F4DC-904C-4C79-9160-78739C238095 Q55353903-3A23CC1A-CC4D-499F-8989-E257934CFC15

P2860

Clinical response to statins: mechanism(s) of variable activity and adverse effects.

http://www.wikidata.org/entity/Q37881964

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical response to statins: mechanism

@nl

Clinical response to statins: mechanism(s) of variable activity and adverse effects.

@en

type

label

Clinical response to statins: mechanism

@nl

Clinical response to statins: mechanism(s) of variable activity and adverse effects.

@en

prefLabel

Clinical response to statins: mechanism

@nl

Clinical response to statins: mechanism(s) of variable activity and adverse effects.

@en

P1433

Q37881964-2FFE1C9A-BC9B-4878-808C-E2F6F764C81C

P1476

Q37881964-A76B7C87-2650-4BFD-9F45-D5C0904BDE70

P2093

Q37881964-0018B91B-8246-4A73-9E44-8B119A11507D

Q37881964-0C7CC865-28CE-4371-8757-4657AAF4B15D

Q37881964-4986DA07-DC0B-458C-9F11-620B389469D1

Q37881964-73092453-7DB2-4842-B624-3B7490A52C39

P2860

Q37881964-01785CF2-B356-4B3D-91F2-5C36BD699FE9

Q37881964-03FDF581-88AF-44C6-8263-6FF3C1215D48

Q37881964-09BED159-4DA9-40C1-BAF4-B246177FE41F

Q37881964-0CDDD225-6A86-43E0-866C-6FC12B4E0AC8

Q37881964-10718537-064A-42AB-804C-BADFD5F4530E

Q37881964-145005E6-047E-41E9-91E7-0C800FE17E9C

Q37881964-1D560FF2-2709-45F1-ADB3-216657F6BA66

Q37881964-2107BD48-A42E-4B6F-A523-F954D2DD96A7

Q37881964-29A85A55-A3E7-4379-AB5E-26BCDA639F3B

Q37881964-2D60B105-736A-4EB3-A07E-E8F2E52E2533

P304

Q37881964-9E35897D-4C5D-4775-A1E5-6D99554C0BAF

P31

Q37881964-2E175AEF-5168-40FA-81EF-8E9EDAA8759E

P356

Q37881964-AE91055E-2549-4167-A3C1-CB48B69038AB

P407

Q37881964-B3510A53-5D74-4CA8-85BD-DFE6B0C75051

P433

Q37881964-95D96EE9-8149-4E7D-8A15-6BA2FC6759DE

P478

Q37881964-D5FA4242-F47B-42C1-90F5-69574D8F1F95

P577

Q37881964-F424C5B2-869B-4E2F-91FF-71D19F89DAB2

P698

Q37881964-71DE2CB9-C37D-49AB-84C6-EB38994CDAB7

P356

07853890.2011.582135

P1433

Annals of Medicine

P1476

Clinical response to statins: mechanism(s) of variable activity and adverse effects.

@en

P2093

Cesare R Sirtori

http://www.w3.org/2001/XMLSchema#string

Giuliana Mombelli

http://www.w3.org/2001/XMLSchema#string

Michela Triolo

http://www.w3.org/2001/XMLSchema#string

Reijo Laaksonen

http://www.w3.org/2001/XMLSchema#string

P2860

Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy

Association between statin-associated myopathy and skeletal muscle damage

Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems

Mutations in ATP-cassette binding proteins G5 (ABCG5) and G8 (ABCG8) causing sitosterolemia

The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction

Impact of apolipoprotein A5 variants on statin treatment efficacy

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants

APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency

3-hydroxy 3-methylglutaryl coenzyme A reductase increase is essential for rat muscle differentiation

P304

419-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/07853890.2011.582135

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21623698

http://www.w3.org/2001/XMLSchema#string